logo
ResearchBunny Logo
Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding

Medicine and Health

Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding

K. Wittwer, D. E. Anderson, et al.

Discover how the orally bioavailable small-molecule polymerase inhibitor ERDRP-0519 could revolutionize measles prevention! This groundbreaking research by Kevin Wittwer, Danielle E. Anderson, and other experts shows promising results in preventing measles disease in squirrel monkeys while reducing virus shedding. Join the fight against measles today!

00:00
00:00
~3 min • Beginner • English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
Medicine and Health

Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review

K. H. Do, D. T. Le, et al.

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Medicine and Health

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

F. Ren, A. Aliper, et al.

Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Medicine and Health

Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer

Y. Zeng, C. Hu, et al.

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial
Medicine and Health

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial

T. Sonoda, Y. Umeda, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny